Moreland School District

Skip to main content
Mobile Menu
More
Español

Easterbrook Discovery School Continues to Set Fundraising Record for Pennies for Patients (R) Program

 

San Jose, June 8, 2017:  Moreland School District announced that Easterbrook Discovery School (EDS) has recently been ranked as the highest individual fundraising school for the Leukemia and Lymphoma Society’s ® Pennies for Patients ® campaign in the Silicon Valley and Monterey Bay Area.  With over 300 schools participating in this region, Easterbrook Discovery School raised $15,676.92, a gain of more than $3,500 from their Number One spot last school year.

Coordinated by 5th grade teacher Katie Morse, EDS has been participating in Pennies for Patients for 13 years.  During a three-week period, students take part in the Student Series, a series of programs for schools and students at all grade levels to help support the LLS mission: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families.  

Pennies for Patients is a three-week program for elementary and middle schools in this Student Series where students collect change and raise funds online while learning about service and philanthropy.  Easterbrook Discovery students collectively raised the money online and in-person by promoting events such as “Stuck for a Buck,” where students pay $1 to duct tape teachers together, or “Dollar Days,” where students pay $1 to dress up as the theme of the day, to name a few.

As a school community, EDS has raised over $81,000 in their past years of participation.  The Moreland School District is incredibly proud to have several schools within the District participate in the Pennies for Patients program every year.  

The Leukemia & Lymphoma Society (LLS) is the world's largest voluntary health agency dedicated to blood cancer.  More than 13 million students and 850,000 educators in 27,000 schools across the U.S. participate annually. Since its beginning, students have raised more than $315 million to fund breakthrough therapies and patient services, and more than $26 million in 2015-2016 alone!